Related Experiment Videos
Bcl-6 protein expression in normal and neoplastic lymphoid tissues
B Falini1, M Fizzotti, S Pileri
1Institute of Hematology, University of Perugia, Italy.
Summary
The study developed antibodies to detect the bcl-6 protein, revealing its role in germinal-center B-cells and its association with lymphomas and Hodgkin's disease.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- The bcl-6 gene is rearranged in approximately 30% of diffuse large B-cell lymphomas (DLCL-B).
- Understanding bcl-6 protein expression is crucial for B-cell lymphoma research.
- Bcl-6 is a Kruppel-type zinc finger protein involved in cellular regulation.
Purpose of the Study:
- To generate and characterize monoclonal antibodies for detecting human bcl-6 protein.
- To investigate the expression patterns of bcl-6 in normal and neoplastic B-cells.
- To explore the potential role of bcl-6 in B-cell differentiation and lymphomagenesis.
Main Methods:
- Generation of two monoclonal antibodies (PG-B6a and PG-B6p) against the human bcl-6 protein.
- Immunization of Balb/c mice with a recombinant bcl-6 protein fragment.
- Immunocytochemistry and immunohistology on various B-cell populations and lymphomas.
- Analysis of bcl-6 expression in relation to gene rearrangements and other cellular markers.
Main Results:
- Bcl-6 protein is primarily localized in the nucleus of normal germinal-center B-cells.
- Strong bcl-6 expression was observed in neoplastic cells of follicular lymphomas, DLCL-B, and Burkitt's lymphomas.
- Bcl-6 immunostaining differentiated proliferation centers in B-CLL from germinal centers in mantle-cell lymphomas.
- Consistent bcl-6 positivity in tumor cells of nodular lymphocyte-predominant Hodgkin's disease (NLPHD).
Conclusions:
- Bcl-6 likely regulates germinal-center functions and B-cell differentiation.
- Aberrant bcl-6 expression may contribute to B-lymphomagenesis.
- Bcl-6 is potentially involved in the pathogenesis of NLPHD, supporting its germinal-center origin.